Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET

被引:7
|
作者
McGeorge, Stephen [1 ,2 ]
Phillips, Reece [3 ]
Rukin, Nicholas J. [2 ,3 ]
Reynolds, Jamie [1 ]
Roberts, Matthew J. [1 ,2 ,3 ,4 ]
机构
[1] Royal Brisbane & Womens Hosp, Dept Urol, Butterfield St, Herston, Qld 4029, Australia
[2] Univ Queensland, Fac Med, Herston, Qld 4006, Australia
[3] Redcliffe Hosp, Dept Urol, Anzac Ave, Redcliffe, Qld 4020, Australia
[4] Univ Queensland, Clin Res Ctr, Fac Med, Bldg 71/918 RBWH Butterfield St, Herston, Qld 4029, Australia
来源
UROLOGY CASE REPORTS | 2021年 / 38卷
关键词
Prostate cancer; Prostate specific membrane antigen; PSMA; Fluorodeoxyglucose; FDG; Adrenalectomy;
D O I
10.1016/j.eucr.2021.101696
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Isolated prostate cancer metastasis to the adrenal gland is rare. We report a case of concordant high uptake in a solitary adrenal metastasis on both prostate-specific membrane antigen and fluorodeoxyglucose positron-emission tomography in a patient with castrate-resistant prostate cancer. Good initial biochemical response was achieved with lapamscopic adrenalectomy. The patient developed lymph node recurrence 12 months later, although remains asymptomatic on hormonal treatment 22 months post-operatively, in keeping with prior results for metastasis-directed therapy which can delay time to additional treatment. Application of dual tracer PET can be valuable for prostate cancer staging and guidance of metastasis-directed treatment.
引用
收藏
页数:3
相关论文
共 34 条
  • [31] 68Ga-PSMA PET/CT Revealing Unusual Inguinal Canal and Distant Nodal Metastasis in a Case of Castration-Resistant Prostate Cancer
    Vadi, Shelvin Kumar
    Kumar, Rajender
    Mittal, Bhagwant Rai
    Singh, Harmandeep
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 279 - 281
  • [32] Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT
    Isik, Emine Goknur
    Has-Simsek, Duygu
    Sanli, Oner
    Sanli, Yasemin
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E54 - E55
  • [33] Dual-Tracer 18F-FDG and 68Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy
    Bian, Linjie
    Li, Panli
    Wang, Xiangwei
    Zuo, Yan
    Liu, Xuwei
    Bai, Liyan
    Lei, Jialiang
    Guo, Haoyao
    Hu, Silong
    Liu, Chang
    Song, Shaoli
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : 143 - 149
  • [34] Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot study
    Pabst, Kim M.
    Mei, Riccardo
    Lueckerath, Katharina
    Hadaschik, Boris A.
    Kesch, Claudia
    Rawitzer, Josefine
    Kessler, Lukas
    Bodensieck, Luisa S.
    Hamacher, Rainer
    Pomykala, Kelsey L.
    Fanti, Stefano
    Herrmann, Ken
    Fendler, Wolfgang P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 52 (01) : 342 - 353